Financial News
Biogen to pay $900M to settle allegations of improper physician kickbacks
September 27, 2022 at 10:38 AM EDT
Biogen is accused of causing submissions of false claims to Medicare and Medicaid by paying physicians kickbacks to prescribe its multiple sclerosis drugs Avonex, Tysabri and Tecfidera.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
